Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > March 8 2022 Investors Summit Presentation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(43)
•••
Post by LithLoveron Mar 17, 2022 12:34am
303 Views
Post# 34520837

March 8 2022 Investors Summit Presentation

March 8 2022 Investors Summit Presentation

New LinkedIn post with link to the latest investment presentation posted yesterday:

"Last week our CEO and CFO presented to investors at the 2022 Virtual Investor Summit. You can watch the presentation under the events section of our website https://ow.ly/eumv50Ik6eH  #EarlyMeansEverything"
 

Events

 
 
Upcoming Events
Investor Summit (Virtual)
March 8 & 9 2022

TCA SEE Summit (Virtual)
April 21, 2022

CEM Conference, Scottsdale AZ
April 22 - 24, 2022
 
 

Past Events

2022 Virtual Investor Summit 3.8.2022
James Howard-Tripp, Chairman and CEO of SZLS and Matthew Pietras, CFO recently presented to investors at the 2022 Virtual Investor Summit. You can watch the full presentation below 

https://www.stagezerolifesciences.com/events.html

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities